MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Novavax Inc

Ouvert

SecteurSoins de santé

7.07 0.14

Résumé

Variation du prix de l'action

24h

Actuel

Min

6.81

Max

7.09

Chiffres clés

By Trading Economics

Revenu

40M

-81M

Ventes

3.8M

88M

BPA

-0.52

Marge bénéficiaire

-91.755

Employés

952

EBITDA

52M

-53M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+101.56% upside

Dividendes

By Dow Jones

Prochains Résultats

9 mai 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-299M

967M

Ouverture précédente

6.93

Clôture précédente

7.07

Score Technique

By Trading Central

Confiance

Very Strong Bullish Evidence

Novavax Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

2 avr. 2025, 17:06 UTC

Principaux Mouvements du Marché

Novavax Falls But Then Recovers After WSJ Report on Vaccine's FDA Status

31 mars 2025, 14:19 UTC

Principaux Mouvements du Marché

Vaccine Stocks Fall After Ousting of FDA's Vaccine Head

4 févr. 2025, 18:52 UTC

Principaux Mouvements du Marché

Psychedelic Drug Stocks Up, Vaccine Shares Down After Senate Committee Advances RFK Jr.

11 nov. 2024, 14:05 UTC

Principaux Mouvements du Marché

Novavax to Move Forward With Covid-19, Influenza Vaccine After FDA Lifts Clinical Hold

16 oct. 2024, 12:59 UTC

Principaux Mouvements du Marché

Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines; Shares Drop

13 mai 2024, 18:14 UTC

Principaux Mouvements du Marché

Novavax Shares Pop Another 50% Following Sanofi Deal

10 mai 2024, 10:59 UTC

Principaux Mouvements du Marché

Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi

30 déc. 2024, 23:02 UTC

Acquisitions, Fusions, Rachats

Novavax Completes Previously Announced $200M Sale of Czech Republic Manufacturing Site to Novo Nordisk

4 déc. 2024, 07:09 UTC

Acquisitions, Fusions, Rachats

Novavax: Agreement to Close by Dec 30 >NVAX

4 déc. 2024, 07:08 UTC

Acquisitions, Fusions, Rachats

Novavax: Sale Aligns With Plan to Become More Lean Organization, Drive Value From Pipeline Assets & Tech Platform >NVAX

4 déc. 2024, 07:07 UTC

Acquisitions, Fusions, Rachats

Novavax: Deal to Also Reduce Annual Operating Costs by About $80M >NVAX

4 déc. 2024, 07:06 UTC

Acquisitions, Fusions, Rachats

Novavax to Get $190M Cash Payment in 2024, Additional $10M in 2025 >NVAX

4 déc. 2024, 07:06 UTC

Acquisitions, Fusions, Rachats

Novavax: Agreement Provides Company With Significant, Non-Dilutive Capital >NVAX

4 déc. 2024, 07:04 UTC

Acquisitions, Fusions, Rachats

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200M

15 nov. 2024, 13:34 UTC

Actualités

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ

15 nov. 2024, 11:14 UTC

Market Talk

U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk

16 oct. 2024, 15:22 UTC

Résultats

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com

10 mai 2024, 20:11 UTC

Résultats

These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital, JFrog, SoundHound, and More -- Barrons.com

10 mai 2024, 14:49 UTC

Résultats
Actions en Tendance

Stocks to Watch Friday: TSMC, Novavax, Nvidia -- WSJ

10 mai 2024, 10:47 UTC

Acquisitions, Fusions, Rachats

Novavax Gets $1.4 Billion Deal With Sanofi. The Stock Jumps. -- Barrons.com

Comparaison

Variation de prix

Novavax Inc prévision

Objectif de Prix

By TipRanks

101.56% hausse

Prévisions sur 12 Mois

Moyen 14.25 USD  101.56%

Haut 19 USD

Bas 9 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

4 ratings

2

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

5.6 / 6.467Support & Résistance

Court Terme

Very Strong Bullish Evidence

Moyen Terme

Bearish Evidence

Long Terme

Weak Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Novavax Inc

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.